(Q68761188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

1 reference

1 reference

J E Baley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

C Meyers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

R M Kliegman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

M R Jacobs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

J L Blumer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

language of work or name

English

0 references

publication date

1 May 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

791-797

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

Candida endophthalmitis in the premature infant

27 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Quantitation of amphotericin B with use of high-pressure liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Computation of model-independent pharmacokinetic parameters during multiple dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

A pharmacologic guide to the clinical use of amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Distribution and activity of amphotericin B in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Pharmacokinetics of amphotericin B in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Pharmacokinetics and adverse effects of amphotericin B in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Renal Tubular Acidosis Due to Amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

THE RENAL LESION RELATED TO AMPHOTERICIN B TREATMENT FOR COCCIDIOIDOMYCOSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Amphotericin B therapy in an anephric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Elimination of amphotericin B in impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Pharmacological Studies with 5-Fluorocytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Bone marrow toxicity associated with 5-fluorocytosine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

Chemotherapy of the systemic mycoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982674-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)82674-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2329429%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference